ÂÜÀòÂÒÂ×

Stephan Eder has held various key positions in the pharmaceutical industry, including being the CEO of Hexal AG and Country Head for Germany at Sandoz. Stephan has also served as the Director of Corporate Strategy at Novartis International AG. In addition, Eder has experience as an Engagement Manager at McKinsey & Company and as a Research and Teaching Assistant at the University of St. Gallen - HSG. Eder is a co-founder and CFO of a biotech startup, 55pharma Drug Discovery & Development AG. Stephan holds a Dr. oec. degree in Business Administration and Management from the University of St.Gallen.